InvestorsHub Logo

axelvento

01/23/19 9:00 AM

#1739 RE: Lazerking40 #1737

laz$ Neutrolin for the prevention of catheter-related blood stream infections in patients with central venous catheters, and believes there is a large market opportunity for Neutrolin in multiple patient populations. CorMedix has Fast-Track designation from the FDA and QIDP designation, leading to 10.5 years of market exclusivity,

multidollar$$$$$